At what coronary calcium score should intervention be initiated?

When Do Calcium Artery Scores Need Intervention?

Coronary artery calcium (CAC) scores do not directly trigger invasive interventions like revascularization, but rather guide the intensity of medical preventive therapy—specifically, CAC ≥100 warrants statin therapy, CAC ≥300-400 indicates high-intensity statin plus aspirin, while CAC = 0 allows deferral of statin therapy in most asymptomatic patients. 1

Understanding CAC Scores as Risk Stratification, Not Intervention Thresholds

A critical distinction: CAC scoring identifies atherosclerotic burden and future cardiovascular risk, but does not indicate need for stress testing or invasive coronary angiography in asymptomatic patients, even with very high scores or multivessel involvement 1. The "intervention" is intensified medical therapy and lifestyle modification, not procedures.

Specific CAC Score Thresholds for Medical Therapy

CAC = 0 (Very Low Risk)

• Defer statin initiation in adults 40-75 years with LDL-C 70-189 mg/dL without diabetes, active smoking, or family history of premature CAD 1
• 10-year event rate <1-3% 2
• Repeat screening in 3-7 years 1, or 3-5 years if risk factors present 2
• Exception: Consider statins if strong family history of premature ASCVD exists 2

CAC 1-99 (Low-Moderate Risk)

• Modest risk reclassification upward 2
• Moderate-intensity statin favored, especially age >55 years 2
• 10-year event rate approximately 7.4% in borderline-risk patients 2

CAC ≥100 (High Risk)

• Initiate statin therapy 1
• Number needed to treat (NNT) to prevent one ASCVD event: 28-30 over 10 years 2
• Consider adding aspirin 81 mg daily 1

CAC ≥300-400 (Very High Risk)

• High-intensity statin therapy mandatory 1
• Consider aspirin 81 mg daily 1
• 10-year cardiovascular risk >20% 2

CAC ≥1,000 (Extremely High Risk)

• High-intensity statin therapy essential 1
• One-third will experience cardiovascular event within 3 years 3
• Aggressive lifestyle modification plus maximal medical therapy 3

Risk-Based Application Algorithm

For Borderline Risk (5-7.5% 10-year ASCVD risk):

• If CAC = 0 and no family history/nonsmoker: Lifestyle modification, withhold statins 2
• If CAC 1-99: Lifestyle modification + moderate-intensity statin 2
• If CAC ≥100: High-intensity statin to reduce LDL-C by ≥50% 2

For Intermediate Risk (7.5-20% 10-year ASCVD risk):

• If CAC = 0: Can reclassify downward, defer statins (especially without smoking/family history) 2
• If CAC 1-99: Moderate-intensity statin 2
• If CAC ≥100 or >75th percentile for age/sex/race: High-intensity statin + aspirin 1, 2

For Low Risk (<5% 10-year ASCVD risk):

• CAC scoring reasonable only with strong family history of premature ASCVD 1
• If CAC = 0: No statin 1
• If CAC >0: Consider moderate-intensity statin based on shared decision-making 2

Critical Pitfalls to Avoid

1. Do not order stress testing or catheterization based solely on high CAC scores in asymptomatic patients—this leads to unnecessary procedures without mortality benefit 1

2. CAC = 0 is not permanent protection: The "warranty period" varies by age and risk factors. Younger patients with diabetes or multiple risk factors need rescreening in 3-5 years, not indefinite deferral 2

3. Do not ignore CAC 1-99: This is not "essentially zero"—it represents a 7.4% 10-year risk in borderline-risk patients and warrants statin consideration 2

4. Statin therapy may increase CAC scores over time due to plaque stabilization and calcification—this is not treatment failure but rather reflects plaque modification 2. Do not discontinue statins based on CAC progression alone.

5. Age and sex matter significantly: Women have substantially lower CAC scores than men at any given age 3. Use age/sex/race-specific percentiles, not just absolute scores 2

Recent Evidence on CAC-Guided Therapy

The 2025 randomized trial in familial CAD demonstrated that CAC score-informed prevention strategies significantly reduced plaque progression compared to usual care (15.4 mm³ vs 24.9 mm³ total plaque volume increase, p=0.009), with particular benefit for noncalcified plaque reduction 4. This supports aggressive preventive therapy when CAC >0 is detected, even in intermediate-risk patients.

The Bottom Line on "Intervention"

The intervention triggered by CAC scoring is medical therapy intensification, not revascularization. CAC ≥100 is the clearest threshold for initiating statins, with CAC ≥300-400 warranting high-intensity statins plus aspirin. CAC = 0 provides reassurance to safely defer statins in most asymptomatic patients, but requires rescreening in 3-5 years if risk factors persist.